RPS2P16

Across TCGA pan-cancer cohorts, RPS2P16 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RPS2P16’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS2P16 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS2P16 is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

COAD, HNSC, and READ are the cancer types where RPS2P16 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS2P16 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.226	<.001	10	view →
HNSC	All	All	+0.126	<.001	5	view →
READ	All	All	+0.352	.005	4	view →
STAD	Male	All	+0.232	.001	4	view →
CHOL	All	All	+0.352	.008	2	view →
KIRP	All	IV	+0.230	.019	2	view →
BRCA	All	III,IV	−0.206	.002	2	view →
BLCA	All	IV	+0.201	.021	2	view →
THCA	Female	All	−0.130	.002	2	view →
LIHC	All	All	+0.077	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

RPS2P16–COAD

Open the COAD breakdown →